A

Alaunos Therapeutics Inc
NASDAQ:TCRT

Watchlist Manager
Alaunos Therapeutics Inc
NASDAQ:TCRT
Watchlist
Price: 5.11 USD 2.2% Market Closed
Market Cap: 8.4m USD

Relative Value

The Relative Value of one TCRT stock under the Base Case scenario is 0.08 USD. Compared to the current market price of 5.11 USD, Alaunos Therapeutics Inc is Overvalued by 98%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TCRT Relative Value
Base Case
0.08 USD
Overvaluation 98%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
41
vs Industry
6
Median 3Y
751
Median 5Y
544.4
Industry
7.3
Forward
0
vs History
vs Industry
Median 3Y
-8.6
Median 5Y
-30.7
Industry
23.3
Forward
5.7
vs History
vs Industry
Median 3Y
-10.5
Median 5Y
-38.3
Industry
19.8
vs History
vs Industry
Median 3Y
-5.7
Median 5Y
-31.7
Industry
22.6
vs History
77
vs Industry
62
Median 3Y
26.7
Median 5Y
40
Industry
2.7
vs History
38
vs Industry
11
Median 3Y
570.8
Median 5Y
486.1
Industry
7.6
Forward
0
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.4
vs History
vs Industry
23
Median 3Y
-9.7
Median 5Y
-34.9
Industry
4.7
vs History
vs Industry
22
Median 3Y
-8.9
Median 5Y
-32.1
Industry
4.8
Forward
0.1
vs History
vs Industry
25
Median 3Y
-10.1
Median 5Y
-37.5
Industry
5.3
vs History
vs Industry
22
Median 3Y
-10
Median 5Y
-37.1
Industry
3.8
vs History
77
vs Industry
64
Median 3Y
49.7
Median 5Y
127.9
Industry
5

Multiples Across Competitors

TCRT Competitors Multiples
Alaunos Therapeutics Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Alaunos Therapeutics Inc
NASDAQ:TCRT
8.2m USD 818.3 -2 -1.9 -1.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 770 229.5 -160 504.9 -194 904.1 -192 680.1
US
Abbvie Inc
NYSE:ABBV
331.4B USD 5.8 79.8 15.2 22.5
US
Amgen Inc
NASDAQ:AMGN
157.5B USD 4.6 26.5 14.3 23.6
US
Gilead Sciences Inc
NASDAQ:GILD
139.2B USD 4.8 23.3 10.1 14
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.1B USD 10.6 -119.4 25.4 26.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 086.1 -532.3 -579.6 -564.2
AU
CSL Ltd
ASX:CSL
119B AUD 5.1 28.2 17.4 21.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
58.2B USD 4.1 12.9 11.5 12.9
US
Seagen Inc
F:SGT
39.3B EUR 20.1 -61.6 -66.4 -59.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
42.2B USD 18 -156.6 -702.8 -352.2
P/E Multiple
Earnings Growth PEG
US
A
Alaunos Therapeutics Inc
NASDAQ:TCRT
Average P/E: 34.1
Negative Multiple: -2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 504.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
79.8
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.5
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.3
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -119.4 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532.3 N/A N/A
AU
CSL Ltd
ASX:CSL
28.2
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.9
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -156.6 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
A
Alaunos Therapeutics Inc
NASDAQ:TCRT
Average EV/EBITDA: 15.7
Negative Multiple: -1.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 904.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.2
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.3
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.4
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.6 N/A N/A
AU
CSL Ltd
ASX:CSL
17.4
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.5
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.4 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -702.8 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
A
Alaunos Therapeutics Inc
NASDAQ:TCRT
Average EV/EBIT: 20.2
Negative Multiple: -1.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 680.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.5
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.6
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
14
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.6
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -564.2 N/A N/A
AU
CSL Ltd
ASX:CSL
21.7
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.9
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -352.2 N/A N/A